Psychedelic Neuroscience

<p>1. An introduction to psychedelic neuroscience<br>Tanya Calvey and Fleur M. Howells<br>2. The renaissance in psychedelic research: What do preclinical models have to offer<br>Kevin S. Murnane<br>3. D-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders<br>Danilo De Gregorio, Justine P. Enns, Nicolas A. Nuñez, Luca Posa and Gabriella Gobbi<br>4. Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition<br>Selen Atasoy, Jakub Vohryzek, Gustavo Deco, Robin L. Carhart-Harris and Morten L. Kringelbach<br>5. A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder<br>Joseph Barsuglia, Martin Polanco, Robert Palmer, Benjamin Malcolm, Benjamin Kelmendi and Tanya Calvey<br>6. Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain<br>Felix Müller, Matthias E. Liechti, Undine E. Lang and Stefan Borgwardt<br>7. Neurocognitive effects of cannabis: Lessons learned from human experimental studies<br>Marco Colizzi and Sagnik Bhattacharyya<br>8. Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers<br>John Martin Corkery</p>